Search company, investor...

Predict your next investment

Corporation
INDUSTRIALS | Basic Materials / Specialty Chemicals
lanxess.com

Investments

5

Portfolio Exits

7

Partners & Customers

10

About LANXESS

LANXESS (OTCMKTS: LNXSF) is a specialty chemicals group. It provides plastics, rubber, specialty chemicals, and intermediates. The company was founded in 2004 and is based in Cologne, Germany.

Headquarters Location

Kennedyplatz 1

Cologne, 50569,

Germany

+49 221 8885 0

Want to inform investors similar to LANXESS about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing LANXESS

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find LANXESS in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest LANXESS News

LANXESS AG : Receives a Buy rating from Berenberg

Sep 22, 2023

LANXESS AG is a Germany-based company engaged in the chemicals sector. It specializes in the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Its business activities are divided into four segments: Specialty Additives, responsible for manufacture of additives for the rubber and paint industries, among others; Advanced Intermediates, focused on the development of intermediates for the agricultural, plastics, chemicals, consumer goods, construction, tire and automotive industries, among others; Performance Chemicals, which offers material protection products, inorganic pigments, finishing agents for the leather industry and resins for water treatment, among others, and Engineering Materials, which produces technical plastics, glass fibers, fiber composites and elastomers on a urethane basis for application in the automotive, electronics and electrical engineering industries. It operates around 60 production sites worldwide. Sector

LANXESS Investments

5 Investments

LANXESS has made 5 investments. Their latest investment was in Arlanxeo as part of their Corporate Minority - II on April 4, 2016.

CBI Logo

LANXESS Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/1/2016

Corporate Minority - II

Arlanxeo

Yes

2

6/24/2013

Series B

Subscribe to see more

$99M

Subscribe to see more

10

2/22/2012

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

5/21/2010

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

5/5/2010

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

0

Date

4/1/2016

6/24/2013

2/22/2012

5/21/2010

5/5/2010

Round

Corporate Minority - II

Series B

Series C - II

Unattributed VC

Corporate Minority

Company

Arlanxeo

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

0

0

LANXESS Portfolio Exits

7 Portfolio Exits

LANXESS has 7 portfolio exits. Their latest portfolio exit was Currenta on November 29, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/29/2019

Acquired

Currenta

$99M

1

8/6/2019

Shareholder Liquidity

Subscribe to see more

$99M

Subscribe to see more

10

8/8/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/27/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/10/2013

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/29/2019

8/6/2019

8/8/2018

7/27/2017

5/10/2013

Exit

Acquired

Shareholder Liquidity

Acquired

Acquired

IPO

Companies

Currenta

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

LANXESS Acquisitions

11 Acquisitions

LANXESS acquired 11 companies. Their latest acquisition was DSM - Engineering Materials Business on January 10, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/10/2023

$99M

Acquired Unit - Fin

2

5/31/2022

$99M

Acquired Unit - Fin

3

8/23/2021

$99M

Acquired Unit

3

4/1/2021

Subscribe to see more

$99M

Subscribe to see more

10

2/16/2021

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/10/2023

5/31/2022

8/23/2021

4/1/2021

2/16/2021

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired Unit - Fin

Acquired Unit - Fin

Acquired Unit

Subscribe to see more

Subscribe to see more

Sources

2

3

3

10

10

LANXESS Partners & Customers

10 Partners and customers

LANXESS has 10 strategic partners and customers. LANXESS recently partnered with FRX Innovations on August 8, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

8/23/2023

Partner

Canada

FRX and LANXESS sign memorandum of understanding to develop partnership

FRX Innovations and LANXESS sign memorandum of understanding to develop partnership

2

6/30/2023

Distributor

Hong Kong

LANXESS appoints Shanghai Perfectech to distribute Lewatit® ion exchange resins

The Liquid Purification Technologies business unit of specialty chemicals company LANXESS AG has entered into a new distribution agreement with Shanghai Perfectech for the supply of its Lewatit ion exchange resins for brine softening in the Chinese chlor-alkali industry effective May 1 , 2023 .

1

5/30/2023

Partner

Canada

1

12/29/2022

Partner

Sweden

Subscribe to see more

Subscribe to see more

10

10/13/2022

Vendor

United States

Subscribe to see more

Subscribe to see more

10

Date

8/23/2023

6/30/2023

5/30/2023

12/29/2022

10/13/2022

Type

Partner

Distributor

Partner

Partner

Vendor

Business Partner

Country

Canada

Hong Kong

Canada

Sweden

United States

News Snippet

FRX and LANXESS sign memorandum of understanding to develop partnership

FRX Innovations and LANXESS sign memorandum of understanding to develop partnership

LANXESS appoints Shanghai Perfectech to distribute Lewatit® ion exchange resins

The Liquid Purification Technologies business unit of specialty chemicals company LANXESS AG has entered into a new distribution agreement with Shanghai Perfectech for the supply of its Lewatit ion exchange resins for brine softening in the Chinese chlor-alkali industry effective May 1 , 2023 .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

LANXESS Team

15 Team Members

LANXESS has 15 team members, including current Chief Executive Officer, President, Ming C. Chien.

Name

Work History

Title

Status

Ming C. Chien

Chief Executive Officer, President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Ming C. Chien

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer, President

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare LANXESS to Competitors

A&B Ingredients Logo
A&B Ingredients

A&B Ingredients supplies a range of vegetable proteins, mold inhibitors, low-sodium sea salt, antimicrobials, shelf-life extenders, probiotics, and pure juice extracts and their derivatives. It also provides technical sales and marketing, importing, distribution, application development, and technical services to the food and fine chemical industries. It was founded in 1990 and is based in Fairfield, New Jersey.

Chinova Bioworks Logo
Chinova Bioworks

Chinova Bioworks focuses on the beverage industry, developing a natural, safe, and effective antimicrobial cocktail mixture. The company provides a targeted or broad-spectrum antimicrobial effect, protecting beverages from spoilage and enhancing their shelf-life. Chinova Bioworks was founded in 2016 and is based in Fredericton, Canada.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.